These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23299034)

  • 1. Ischemic heart disease in patients undergoing dialysis.
    Ariyamuthu VK; Balla S; Chaudhary K
    Hosp Pract (1995); 2012 Oct; 40(4):33-9. PubMed ID: 23299034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac troponin T and end stage renal disease.
    Gabr AE; Ibrahim IA; Aloulou SM; Al-Alfi MA; Al-Abdlrahim KA
    Saudi Med J; 2004 Aug; 25(8):1015-9. PubMed ID: 15322590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic renal dysfunction as an independent risk factor for the development of cardiovascular disease.
    Varma R; Garrick R; McClung J; Frishman WH
    Cardiol Rev; 2005; 13(2):98-107. PubMed ID: 15705261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.
    Wszola M; Kwiatkowski A; Nosek R; Podsiadly E; Meszaros J; Danielewicz R; Lisik W; Ostrowski K; Chmura A; Adadyński L; Paczek L; Durlik M; Tylewska-Wierzbanowska S; Rowiński W
    Transplant Proc; 2006; 38(1):31-4. PubMed ID: 16504656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis-induced myocardial stunning: the other side of the cardiorenal syndrome.
    Breidthardt T; McIntyre CW
    Rev Cardiovasc Med; 2011; 12(1):13-20. PubMed ID: 21546884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular complications in end-stage renal disease and hemodialysis patients.
    Kes P; Drusko D; Rupcić V
    Acta Med Croatica; 1996; 50(4-5):199-208. PubMed ID: 9046118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
    Oda H; Ohno M; Ohashi H
    Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis.
    Fernández-Reyes MJ; Mon C; Heras M; Guevara P; Garcia MC; Sanchez R; Velasco S; Alvarez-Ude F
    J Nephrol; 2004; 17(5):721-7. PubMed ID: 15593041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperphosphatemia and cardiovascular risk in patients on dialysis].
    Basić-Jukić N; Kes P
    Acta Med Croatica; 2004; 58(3):207-13. PubMed ID: 15503684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial stunning in hemodialysis: what is the overall message?
    Dorairajan S; Chockalingam A; Misra M
    Hemodial Int; 2010 Oct; 14(4):447-50. PubMed ID: 20955278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological adequacy--what does it mean?].
    Kes P; Basić-Jukić N; Brunetta B
    Acta Med Croatica; 2004; 58(1):1-4. PubMed ID: 15125386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advances in the prevention of cardiovascular morbidity and mortality in end-stage renal disease: role of anemia, hyperparathyroidism and calcifications].
    Del Vecchio L; Pozzoni P; Limardo M; Caruso S; Fortunato M; Pontoriero G; Locatelli F
    G Ital Nefrol; 2007; 24 Suppl 38():25-32. PubMed ID: 17922444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients.
    Zhou Q; Wu S; Jiang J; Tian J; Chen J; Yu X; Chen P; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Xie DI; Liu J; Xu X; Liang M; Hou F
    Nephrology (Carlton); 2012 Sep; 17(7):642-9. PubMed ID: 22738256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does early anemia correction prevent complications of chronic renal failure?
    Drüeke TB; Eckardt KU; Frei U; Jacobs C; Kokot F; McMahon LP; Schaefer RM
    Clin Nephrol; 1999 Jan; 51(1):1-11. PubMed ID: 9988140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patients.
    Pernod G; Bosson JL; Golshayan D; Barro C; Alloatti S; Turc-Baron C; Quarello F; Jeantet A; Von Albertini B; Forêt M; Lauren G; Cordonnier D; Piccoli G; Wauters JP;
    J Nephrol; 2004; 17(1):66-75. PubMed ID: 15151261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure in patients with chronic kidney disease.
    Lisowska A; Musiał WJ
    Rocz Akad Med Bialymst; 2004; 49():162-5. PubMed ID: 15631334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmias in hemodialysis patients.
    Voroneanu L; Covic A
    J Nephrol; 2009; 22(6):716-25. PubMed ID: 19967650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of cardiovascular death in ESRD.
    Zoccali C; Tripepi G; Mallamaci F
    Semin Nephrol; 2005 Nov; 25(6):358-62. PubMed ID: 16298255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.